Nce to hormone therapy, thereby requiring far more aggressive treatment. For HER
Nce to hormone therapy, thereby requiring more aggressive treatment. For HER2+ breast cancers, treatment using the targeted inhibitor trastuzumab may be the common course.45,46 Even though trastuzumab is effective, nearly…